[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases. The company's lead product candidate includes SL-325, a DR3 blocking monoclonal antibody, which activates immune responses through binding a single receptor, DR3; and SL-425. It also develops multiple preclinical DR3-based bispecific antibodies for the treatment of inflammatory bowel disease; and a series of bispecific antibodies targeting DR3 and other clinically validated targets. In addition, the company is involved in the advancement of its lead TRIM7 inhibitors through preclinical development as future internal pipeline candidates in oncology. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 44, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 44, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 742560, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 581936, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.", "age": 65, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 639654, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 51, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "age": 49, "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 53, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Co-Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Co-Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelli  Collin M.S.", "title": "Senior Vice President of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8947, "open": 0.9, "dayLow": 0.9, "dayHigh": 0.9749, "regularMarketPreviousClose": 0.8947, "regularMarketOpen": 0.9, "regularMarketDayLow": 0.9, "regularMarketDayHigh": 0.9749, "payoutRatio": 0.0, "beta": 1.636, "forwardPE": -0.8971962, "volume": 489068, "regularMarketVolume": 489068, "averageVolume": 1905901, "averageVolume10days": 648670, "averageDailyVolume10Day": 648670, "bid": 0.935, "ask": 0.9822, "bidSize": 2, "askSize": 2, "marketCap": 45987072, "fiftyTwoWeekLow": 0.692, "fiftyTwoWeekHigh": 3.95, "priceToSalesTrailing12Months": 15.344368, "fiftyDayAverage": 0.86716, "twoHundredDayAverage": 1.06148, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1507913, "profitMargins": 0.0, "floatShares": 24148969, "sharesOutstanding": 47903200, "sharesShort": 431826, "sharesShortPriorMonth": 754834, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.009, "heldPercentInsiders": 0.1436, "heldPercentInstitutions": 0.59027, "shortRatio": 1.88, "shortPercentOfFloat": 0.0134000005, "impliedSharesOutstanding": 47903200, "bookValue": 1.19, "priceToBook": 0.80672264, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -61514000, "trailingEps": -1.21, "forwardEps": -1.07, "enterpriseToRevenue": -0.503, "enterpriseToEbitda": 0.025, "52WeekChange": -0.734072, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 0.96, "targetHighPrice": 2.0, "targetLowPrice": 0.92, "targetMeanPrice": 1.46, "targetMedianPrice": 1.46, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 50467000, "totalCashPerShare": 1.054, "ebitda": -61002000, "totalDebt": 2972000, "quickRatio": 9.458, "currentRatio": 10.246, "totalRevenue": 2997000, "debtToEquity": 5.212, "revenuePerShare": 0.059, "returnOnAssets": -0.41946, "returnOnEquity": -0.7339, "grossProfits": 15007000, "freeCashflow": -33668000, "operatingCashflow": -55899000, "grossMargins": 5.00734, "ebitdaMargins": 0.0, "operatingMargins": -21.608269, "financialCurrency": "USD", "symbol": "STTK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Shattuck Labs, Inc.", "regularMarketChangePercent": 7.29853, "regularMarketPrice": 0.96, "shortName": "Shattuck Labs, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602250200000, "postMarketChangePercent": -2.0937498, "postMarketPrice": 0.9399, "postMarketChange": -0.020099998, "regularMarketChange": 0.0653, "regularMarketDayRange": "0.9 - 0.9749", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1905901, "fiftyTwoWeekLowChange": 0.268, "fiftyTwoWeekLowChangePercent": 0.38728327, "fiftyTwoWeekRange": "0.692 - 3.95", "fiftyTwoWeekHighChange": -2.99, "fiftyTwoWeekHighChangePercent": -0.756962, "fiftyTwoWeekChangePercent": -73.4072, "exchange": "NMS", "messageBoardId": "finmb_378179277", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1755901036, "regularMarketTime": 1755892800, "earningsTimestamp": 1755174600, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.21, "epsForward": -1.07, "epsCurrentYear": -0.84359, "priceEpsCurrentYear": -1.1379936, "fiftyDayAverageChange": 0.09283996, "fiftyDayAverageChangePercent": 0.10706208, "twoHundredDayAverageChange": -0.10148007, "twoHundredDayAverageChangePercent": -0.09560242, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-09", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Shattuck Labs", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]